FASENRA is now the only respiratory biologic that offers the choice of administration at home or in a doctor’s office with eight-week maintenance dosing WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca ...
The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. The patients prefer the self-injection method as it is easy to use, cost-effective, and ...
CNW/ - Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun Pharma"), is pleased ...
Vabysmo now covered across all three approved indications in the province, giving patients a comprehensively funded option for their needs Logo de Roche Canada (CNW Group/Hoffmann-La Roche Limited ...
Vabysmo now covered across all three approved indications in the province, giving patients a comprehensively funded option for their needs "We are pleased this milestone provides ophthalmologists and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback